Adorbs Inc
company.status.inactiveCIK 1726822fmd_17QJS2R8G4B5272DJ7MTGTMQQ5Manufacturing · Medicinal Chemicals & Botanical ProductsTemplate: Standard
Coverage: Jan 01, 2017 to Sep 30, 2023, 22 periods
| Line item | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 |
|---|---|---|---|---|---|
| Total revenues | 0 | 0 | 0 | 0 | 0 |
| Cost of revenue | 0 | 0 | 0 | – | 0 |
| Net interest income | 0 | – | – | 0 | (0) |
| Gross profit | 0 | 0 | 0 | 0 | 0 |
| Research and development | 0 | – | – | – | – |
| Total operating expenses | 0 | 0 | 0 | 0 | 1 |
| Operating income | (0) | (0) | (0) | (0) | (0) |
| Interest and investment income | – | 0 | 0 | 0 | – |
| Other non-operating income (expense) | 0 | – | 0 | 0 | (0) |
| Income before taxes | – | – | (0) | (0) | (0) |
| Net income | (0) | (0) | (0) | (0) | (0) |
| Net income to common shareholders | – | – | 0 | 0 | 0 |